Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
Go back to Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 1.27 +0.03 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.24 | 52 Week High | $11.69 | |||
| Open | $1.24 | 52 Week Low | $4.50 | |||
| Day High | $1.27 | P/E | N/A | |||
| Day Low | $1.22 | EPS | $-0.28 | |||
| Volume | 1,917,768 | |||||
